In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2
作者： Robert A Smith , , Dana N Raugi , Charlotte Pan , Papa Salif Sow
DOI: 10.1186/S12977-015-0146-8
关键词:
摘要: … Virus stocks were generated by transient transfection of chloroquine-treated 293T/17 cultures with plasmids pNL4-3 and pROD9, respectively. Dolutegravir was obtained from Selleck …
biomedcentral.com
springer.com
core.ac.uk
paperity.org参考文章(72)
Kazuya Shimura, Eiichi Kodama, Yasuko Sakagami, Yuji Matsuzaki, Wataru Watanabe, Kazunobu Yamataka, Yasuo Watanabe, Yoshitsugu Ohata, Satoki Doi, Motohide Sato, Mitsuki Kano, Satoru Ikeda, Masao Matsuoka, Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137) Journal of Virology. ,vol. 82, pp. 764- 774 ,(2008) , 10.1128/JVI.01534-07
Vincent Cutillas, Thibault Mesplede, Kaitlin Anstett, Said Hassounah, Mark A. Wainberg, The R262K Substitution Combined with H51Y in HIV-1 Subtype B Integrase Confers Low-Level Resistance against Dolutegravir Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 310- 316 ,(2015) , 10.1128/AAC.04274-14
T. Mesplede, N. Osman, M. Wares, P. K. Quashie, S. Hassounah, K. Anstett, Y. Han, D. N. Singhroy, M. A. Wainberg, Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity Journal of Antimicrobial Chemotherapy. ,vol. 69, pp. 2733- 2740 ,(2014) , 10.1093/JAC/DKU199
Geoffrey S. Gottlieb, Robert A. Smith, Ndeye Mery Dia Badiane, Selly Ba, Stephen E. Hawes, Macoumba Toure, Alison K. Starling, Fatou Traore, Fatima Sall, Stephen L. Cherne, Joshua Stern, Kim G. Wong, Paul Lu, Moon Kim, Dana N. Raugi, Airin Lam, James I. Mullins, Nancy B. Kiviat, , HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa PLoS ONE. ,vol. 6, pp. e22204- ,(2011) , 10.1371/JOURNAL.PONE.0022204
Alun Wynn-Williams, "ANTI-ANTI" The Lancet. ,vol. 304, pp. 1389- ,(1974) , 10.1016/S0140-6736(74)92262-4
Marie Camille Cot, Michele Poulain, J.F. Delagneau, Dual HIV-1 and HIV-2 infection in West Africa supported by synthetic peptide analysis. AIDS Research and Human Retroviruses. ,vol. 4, pp. 239- 241 ,(1988) , 10.1089/AID.1988.4.239
Adeeba Binti Kamarulzaman, AIDS Res Hum Retroviruses ,(2006)
Thibault Mesplède, Peter K. Quashie, Mark A. Wainberg, Resistance to HIV integrase inhibitors. Current Opinion in Hiv and Aids. ,vol. 7, pp. 401- 408 ,(2012) , 10.1097/COH.0B013E328356DB89
Yue Zheng, Christine Lambert, Vic Arendt, Carole Seguin-Devaux, Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naïve HIV-2-infected patient. AIDS. ,vol. 28, pp. 2329- 2331 ,(2014) , 10.1097/QAD.0000000000000414
Charlotte Charpentier, Lucile Larrouy, Gilles Collin, Florence Damond, Sophie Matheron, Geneviève Chêne, Ting Nie, Raymond Schinazi, Françoise Brun-Vézinet, Diane Descamps, In-vitro phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitor S/GSK1349572. AIDS. ,vol. 24, pp. 2753- 2755 ,(2010) , 10.1097/QAD.0B013E32833F9E36